Clinical Trial Update: The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

View source ↗

Summary

This clinical trial investigates whether coexisting TMPRSS2-ERG gene fusion and PTEN deletion predict outcomes in prostate cancer patients with biochemical fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Prostate Cancer | Status: RECRUITING